Tumor-derived cell-free DNA detected in cerebrospinal fluid enables…
Doctors can now analyze brain tumors from spinal fluid samples instead of repeated surgery, offering children with this difficult cancer a gentler way to track treatment progress.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Prognostic and therapeutic implications of BRAF mutations in acute…
Genetic testing for BRAF mutations in certain blood cancers reveals which patients might benefit from existing targeted drugs, opening precision treatment options for a stubborn disease.
Novel or significantly improved treatmentLiposomal mitoxantrone plus tislelizumab in patients with relapsed or…
A new drug combination shows promise for patients with a rare, aggressive lymphoma that usually fails standard treatment, offering hope where options were previously limited.
Near-term implementable findingLongitudinal validation of ENLIGHT, an AI predictor of immunotherapy…
An AI tool that predicts which patients will respond to immunotherapy gains stronger validation across multiple cancer types, potentially helping doctors choose treatments more accurately.
Promising but preliminary3D multi-omics tumour atlases
New mapping technologies reveal tumor structure at multiple biological levels simultaneously, creating a clearer blueprint for designing personalized cancer treatments.